News

iTrack™ Canaloplasty to be Featured at the 2024 Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Annual Congress

Media Release iTrack

1 Nov, 2024

Nova Eye to Feature Several Presentations and Posters Related to iTrack Canaloplasty at 2024 ESCRS Annual Congress

Media Release General iTrack Molteno3 AlphaRET

2 Aug, 2024

iTrack™ Canaloplasty to be Featured at the 2024 Women in Ophthalmology (WIO) Summer Symposium

Media Release General iTrack Molteno3 AlphaRET

24 Jul, 2024

iTrack™ Canaloplasty to be Featured at the 2024 World Ophthalmology Congress (WOC)

Media Release General iTrack Molteno3 AlphaRET

24 Jul, 2024

iTrack™ Canaloplasty to be Featured at the International Congress of German Ophthalmic Surgery (DOC) 2024

Media Release iTrack

11 Jun, 2024

iTrack™ Canaloplasty to be Featured in 31 Presentations in the Official 2024 ASCRS Annual Meeting

Media Release General iTrack Molteno3 AlphaRET

22 Mar, 2024

iTrack™ Canaloplasty to be Featured at the 2024 American Glaucoma Society (AGS) Annual Meeting

Media Release General iTrack Molteno3 AlphaRET

23 Jan, 2024

6-Year Data Published in Journal of Glaucoma Demonstrates Effective, Sustained Reduction in Intraocular Pressure with iTrack™ Canaloplasty

Media Release iTrack

2 Nov, 2023

Preliminary Clinical Data Highlights Potential to Expand Addressable Market to include Angle Closure Glaucoma

Media Release iTrack

25 Oct, 2023

iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna

Media Release General iTrack Molteno3 AlphaRET

1 Sep, 2023

iTrack™ Advance to be Featured at the 10th World Glaucoma Congress

Media Release iTrack

23 Jun, 2023

iTrack™ Canaloplasty to be Featured at the Congress of German Ophthalmic Surgery (DOC) 2023

Media Release General iTrack Molteno3 AlphaRET

15 Jun, 2023

iTrack™ Advance to be Featured at 35th APACRS Annual Meeting, Singapore

Media Release iTrack

8 Jun, 2023

iTrack™ Canaloplasty to be Featured in Numerous Scientific Presentations at the ASCRS 2023 Annual Meeting

Media Release iTrack

4 May, 2023

iTrack™ Canaloplasty to be Featured at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Media Release iTrack

23 Apr, 2023

USA Clearance of iTrack™ Advance Canaloplasty Device

Media Release iTrack

12 Apr, 2023

iTrack™ Canaloplasty to be Featured at the 2023 American Glaucoma Society (AGS) Annual Meeting

Media Release iTrack

7 Mar, 2023

iTrack™ Canaloplasty to be Featured at the 2023 American Glaucoma Society (AGS) Annual Meeting

Media Release iTrack

3 Mar, 2023

iTrack™ Canaloplasty to be Featured at the 2023 Asia-Pacific Academy of Ophthalmology Congress (APAO)

Media Release iTrack

23 Feb, 2023

Nova Eye Medical Launches Multi-Center ‘CATALYST’ Study in Europe to Investigate Canaloplasty with the new iTrack™ Advance

Media Release iTrack

11 Aug, 2022

Nova Eye Medical Announces Global Data Registry to Support Role of Canaloplasty for Glaucoma

Media Release iTrack

4 Aug, 2022

Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance

Media Release General iTrack

19 Apr, 2022

iTrack™ Canaloplasty to be Featured at the 2022 ASCRS Annual Meeting

Media Release General iTrack

12 Apr, 2022

Nova Eye, Inc., President Appointed to American Glaucoma Society (AGS) Foundation Advisory Board

Media Release General iTrack

31 Mar, 2022

iTrack™ to be Featured at the 2022 American Glaucoma Society (AGS) Annual Meeting

Media Release iTrack

8 Mar, 2022

2RT® Featured at the 2021 Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Media Release General AlphaRET

3 May, 2021

Positive Five-Year Post-LEAD Trial Results for 2RT®

Media Release General AlphaRET

5 Mar, 2021

Clinical Update: 2RT® Improves Retinal Function in Cases of Intermediate AMD

Media Release AlphaRET

16 Nov, 2020

Nova Eye Medical Establishes "AlphaRET" to Fulfil the Commercial Development of 2RT®

Media Release AlphaRET

26 Oct, 2020

Multicenter Study Highlights Surgical Efficiency of the Molteno3® Glaucoma Drainage Device

Media Release Molteno3

5 Aug, 2020

Nova Eye Medical Acquires Molteno3 Glaucoma Drainage Device Portfolio

Media Release Molteno3

6 Jul, 2020

For media enquires please contact:

Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More